Moody's Ratings affirms Astellas' A3 rating; outlook remains stable (Japanese)
2025 年10月20日、 東京、 ムーディーズ・ ジャパン株式会社（ 以下「ムーディーズ」） は、 アステ ラス製薬株式会社（ 以下「アステラス製薬」） の発行体格付A3を確認した。 格付の見通しは引き 続き安定的である。. 「 アステラス製薬の格付A3の確認は、 同社が規律ある財務方針のもとでフリーキャッシュフロー...
Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:
- 130 countries
11,000 corporate issuers
21,000 public finance issuers
76,000 structured finance obligations
Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.
Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.